Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to better understand the immune response to basal cell carcinoma
(BCC) treated with Photodynamic Therapy (PDT) in order to develop new methods of treating
BCC. Previous research suggests that PDT alters the immune response, possibly in a way that
could promote better tumor clearance when combined with other treatments. Overall,
participation in this study will help the study team better understand the anti-tumor immune
response when BCC is treated with PDT.